Expression and function of classical protein kinase C isoenzymes in gastric cancer cell line and its drug-resistant sublines

World Journal of Gastroenterology

Volumn 8, Issue 3, 2002, Pages 441-445

  Han, Ying ^a   Han, Zhe Yi ^a   Zhou, Xin Min ^a   Shi, Ru ^a   Zheng, Yue ^a   Shi, Yong Quan ^a   Miao, Ji Yan ^a   Pan, Bo Rong ^a   Fan, Dai Ming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; ENZYME ANTIBODY; ISOENZYME; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA 1; PROTEIN KINASE C BETA 2; PROTEIN KINASE C GAMMA; UNCLASSIFIED DRUG; VINCRISTINE;

ARTICLE; CANCER CELL CULTURE; COMPARATIVE STUDY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG RETENTION; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MULTIDRUG RESISTANCE; PHENOTYPE; PROTEIN EXPRESSION; STAINING; STOMACH CANCER; WESTERN BLOTTING;

EID: 0036286197     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v8.i3.441     Document Type: Article

References (80)

1. Detection of multidrug resistance gene in progressive colon cancer and its significance
2. Effect of trichosanthin on cytotoxicity and induction of apoptosis of multidrugs resistance cells in gastric cancer
3. Abnormal drug accumulation in multidrug resistant gastric carcinoma cells
4. Congenital expression of Mdr-1 gene in tissues of carcinoma and its relation with pathomorphology and prognosis
5. Wild type p53 sensitizes soft tissue sarcoma cells to doxorubicin by down-regulating multidrug resistance-1 expression
6. Effects of Taxotere on invasive potential and multidrug resistance phenotype in pancreatic carcinoma cell line SUIT-2
7. Antisense to cyclin D1 reverses the transformed phenotype of human gastric cancer cells
8. Down regulation of Hsp90 could change cell cycle distribution and increase drug sensitivity of tumor cells
9. Two novel gastric cancer associated genes identified by differential display
10. Transduction of Fas gene or Bcl-2 antisense RNA sensitizes cultured drug resistant gastric cancer cells to chemotherapeutic drugs
11. The preferential induction of apoptosis in multidrug-resistant KB cells by 5-fluorouracil
12. pH and multidrug resistance
13. Cytoskeleton elements mediate the inhibition of the (Na(+) + K(+)) atpase activity by PKC in Rhodnius prolixus malphighian tubules during hyperosmotic shock
14. Phorbol ester impairs electrical excitation of rat pancreatic beta-cells through PKC-independent activation of KATP channels
15. Convergence of PKC-dependent kinase signal cascades on NMDA receptors
16. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and varepsilon PKC
17. Activation of PKC-beta (I) in glomerular mesangial cells is associated with specific NF-kappaB subunit translocation
18. Role of PKC and MAP kinase in EGF- and TPA-induced connexin43 phosphorylation and inhibition of gap junction intercellular communication in rat liver epithelial cells
19. Activation of MAPK by TRH requires clathrine-dependent endocytosis and PKC but not receptor interaction with beta-arrestin or receptor endocytosis
20. PKC-beta1 mediates EGF protection of microtubules and barrier of intestinal monolayers against oxidants
21. Cross-talk between PKA and PKC in human fibroblasts: What are the pharmacotherapeutic implications?
22. Age-dependent activation of PKC isoforms by angiotensin II in the proximal nephron
23. Protein phosphatase 2B inhibitor potentiates endothelial PKC activity and barrier dysfunction
24. Toward the identification of selective modulators of protein kinase C (PKC) isozymes: Establishment of a binding assay for PKC isozymes using synthetic C1 peptide receptors and identification of the critical residues involved in the phorbol ester binding
25. The activation of PI 3-K and PKC zeta in PMA-induced differentiation of HL-60 cells
26. Involvement of PKC-beta in PTH, TNF-alpha, and IL-1 beta effects on IL-6 promoter in osteoblastic cells and on PTH-stimulated bone resorption
27. Effects of Cordyceps polysaccharides in patients with chronic hepatitis C
28. Clinical significance of endotoxemia in liver diseases
29. Expression of chromogranin C/secretogranin II and pancreastatin in the pancreatic ductal carcinoma
30. Significance of cathepsin D and chromogranin A expression in human primary hepatocellular carcinomas
31. Study on causes of serum anti-HBs positive patients with chronic liver diseases
32. Expression of Fas gene in gastric cancer cells transducted with Fas gene
33. Preparation and activity of conjugate of monoclonal antibody HAb18 against hepatoma F (ab′) 2 fragment and staphylococcal enterotoxin A
34. Virulence and potential pathogenicity of coccoid Helicobacter pylori induced antibiotics
35. Expression of adhesion molecules in tissues and peripheral lymphocyte of patients with ulcerative colitis
36. Significance of proliferating cell nuclear antigen expression in colorectal carcinomas
37. Co-regulative effects of the cAMP/PKA and DAG/PKC signal pathways on human gastric cancer cells during differentiation induced by traditional Chinese medicines
38. Effects of Taxotere on invasive potential and multidrug resistance phenotype in pancreatic carcinoma cell line SUIT-2
39. Expression of mdr1 gene coded P glycoprotein in hepatocellular carcinoma and its clinical significance
40. Expression significance of mdr1 gene in gastric carcinoma tissue
41. Construction of eukaryotic expression vector pBK fas and MDR reversal test of drug-resistant gastric cancer cells
42. The expression of p53 C-myc and P-gp proteins in gastric cancer
43. Suppression of P-gp induced multiple drug resistance in a drug resistant gastric cancer cell line by overexpression of Fas
44. Multidrug resistance gene (MDR-1) expression as a useful prognostic factor ini patients with human hepatocellular carcinoma after surgical resection
45. Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas
46. Cytotoxic treatment of adrenocortical carcinoma
47. Structure-activity relationships and optimisation of the selective MDR modulator 2-(3,4-dimethoxyphenyl)-5-(9-fluorenylamino)-2-(methylethyl) pentanenitrile and its N-methyl derivative
48. Cross-resistance to cytosine arabinoside in a multidrug-resistant human promyelocytic cell line selected for resistance to doxorubicin: Implications for combination chemotherapy
49. Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme-DNA cleavage complexes
50. Structure of MsbA from E. coli: A homolog of the multidrug resistance ATP binding cassette (ABC) transporters
51. Regulation of MDR1 promoter activity in human breast carcinoma cells by protein kinase C isozymes alpha and theta
52. Differential effects of the MDR1 (multidrug resistance) gene-activating agents on protein kinase C: Evidence for redundancy of mechanisms of acquired MDR in leukemia cells
53. Increased phosphorylation of DNA topoisomerase II in etoposide resistant mutants of human glioma cell line
54. Lipids: A key role in multidrug resistance?
55. Pharmacokinetics and metabolism of the staurosporine analogue CGP 41 251 in mice
56. The bisindolylmaleimide protein kinase C inhibitor, Ro 32-2241, reverses multidrug resistance in KB tumour cells
57. Expression of P-gp and PKC isoenzymes in multidrug resistance gastric cancer cell-line SGC7901/VCR
58. Expression and function of PKC isoenzymes PKC-α and PKC-βI in gatric cancer cell-line SGC 7901 and its subline SGC7901/VCR
59. Protein kinase C is related to multidrug resistance by MGr1-Ag
60. Expression and distribution of PKC isoenzymes in swelling activated multidrug resistance gastric cancer cell-line
61. Relationship between DNA ploidy, expression of ki 67 antigen and gastric cancer metastasis
62. Consequence alimentary reconstruction in nutritional status after total gastrectomy for gastric cancer
63. Study of differential polymerase chain reaction of C-erbB 2 oncogene amplification in gastric cancer
64. Telomerase activity in gastric cancer and its clinical implications
65. Study on the expression of matrix metallo proteinase 2Mrna in human gastric cancer
66. Study on incisional implantation of tumor cells by carbon dioxide pneumo peritoneum in gastric cancer of a murine model
67. A clinical and long term follow up study of peri operative sequential triple therapy for gastric cancer
68. Helicobacter pylori infection and risk of gastric cancer in Changle County, Fujian Province, China
69. Antisense telomerase RNA induced human gastric cancer cell apoptosis
70. A study on arsenic trioxide inducing in vitro apoptosis of gastric cancer cell lines
71. Relationship between collagen IV expression and biological behavior of gastric cancer
72. Induction of apoptosis by arsenic trioxide and hydroxy camptothecin in gastric cancer cells in vitro
73. Study on the risk factors of lymphatic metastasis and the indications of less invasive operations in early gastric cancer
74. Progress of gastric cancer etiology: Nnitrosamides in the 1990s
75. Multiple genetic alterations and behavior of cellular biology in gastric cancer and other gastric mucosal lesions: H. pylori infection, histological types and staging
76. Helicobacter pylori and gastric cancer: Current status of the Austrian-Czech-German gastric cancer prevention trial (PRISMA study)
77. Function of apoptosis and expression of the proteins Bcl-2, p53 and C-myc in the development of gastric cancer
78. Glutathione S-transferases M1, T1 genotypes and the risk of gastric cancer: A case control study
79. Expression, deletion and mutation of p16 gene in human gastric cancer
80. Telomere erosion is independent of microsatellite instability but related to loss of heterozygosity in gastric cancer